ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 264 filers reported holding ALKERMES PLC in Q1 2015. The put-call ratio across all filers is 0.36 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,456,609 | +694.0% | 373,317 | +595.2% | 0.05% | +477.8% |
| Q2 2021 | $1,317,000 | +50.3% | 53,701 | +22.4% | 0.01% | +28.6% |
| Q4 2020 | $876,000 | -40.0% | 43,888 | -41.6% | 0.01% | -58.8% |
| Q2 2020 | $1,459,000 | +14.8% | 75,191 | +20.7% | 0.02% | -32.0% |
| Q4 2019 | $1,271,000 | -32.9% | 62,315 | -25.8% | 0.02% | -51.9% |
| Q2 2019 | $1,893,000 | +129.7% | 83,965 | +272.0% | 0.05% | +108.0% |
| Q1 2019 | $824,000 | -81.8% | 22,570 | -70.9% | 0.02% | -77.3% |
| Q1 2017 | $4,533,000 | -12.3% | 77,482 | -16.7% | 0.11% | -0.9% |
| Q4 2016 | $5,167,000 | +537.1% | 92,968 | +637.8% | 0.11% | +170.7% |
| Q2 2015 | $811,000 | -83.3% | 12,600 | -84.2% | 0.04% | -82.5% |
| Q1 2015 | $4,848,000 | – | 79,518 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 14,040,000 | $313,513,000 | 35.43% |
| Krensavage Asset Management, LLC | 1,411,682 | $31,523,000 | 10.04% |
| Prosight Management, LP | 502,150 | $11,213,000 | 6.01% |
| Hardman Johnston Global Advisors LLC | 5,734,259 | $128,046,000 | 5.76% |
| 13D Management LLC | 415,055 | $9,268,000 | 4.85% |
| Ally Bridge Group (NY) LLC | 300,000 | $6,699,000 | 4.42% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 593,000 | $13,248,000 | 4.25% |
| GREAT POINT PARTNERS LLC | 507,500 | $11,332,000 | 2.73% |
| Tamarack Advisers, LP | 200,000 | $4,466,000 | 2.62% |
| Zebra Capital Management LLC | 22,134 | $494,000 | 1.88% |